Montelukast Prescribing at ROSEDEAN SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,255
Total Quantity
34.2K
NHS Cost
£2.3K
vs National Avg
+83.3%
ROSEDEAN SURGERY prescribed 1,255 items of Montelukast over the last 12 months at a cost of £2,335 to the NHS. This is 83.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
118
Jun 2026
115
Jun 2026
115
Jun 2026
126
Jun 2026
125
Jun 2026
111
Jun 2026
96
Jun 2026
113
Jun 2026
100
Jun 2026
72
Jun 2026
78
Jun 2026
86
Prescribing Details
| Total Items | 1,255 |
|---|---|
| Total Quantity | 34,172 |
| Total NHS Cost | £2,335 |
| Presentations | 4 different forms |
| vs National Average | +83.3% |
Montelukast Prescribing Comparison
| This practice | 1,255 items |
|---|---|
| National average per practice | 685 items |
| Difference | +83.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.